Why you should attend The Digital International Liver Congress™ 2020
Every year, scientific and medical experts from a broad range of fields including hepatology, gastroenterology, internal medicine, cell biology, transplant surgery, infectious diseases, microbiology, virology, pharmacology, pathology, radiology, and imaging, come together from around the world at the International Liver Congress™ to learn about the latest in liver research. This year, owing to COVID-19 disruptions, the event is being held entirely online, as The Digital International Liver Congress™ 2020.
- ILC is EASL’s annual flagship congress and attracts around 10,000 delegates and 250 media representatives from all over the world
- Specialists share recent data, present studies, and findings
- Discuss the hottest topics on liver disease
- Excellent international networking opportunity
Discover the Digital ILC 2020 scientific programme.
The Digital International Liver Congress™ 2020
At the Digital International Liver Congress™ 2020, EASL is turning its attention to health in daily life and its importance in protecting the liver. Doctors, patients and patient groups, allied health professionals, and policymakers will discuss important new insights and information to help combat liver disease.
Attendees will hear the latest epidemiological and real-world data on the latest liver research.
EASL’s principles and values
EASL is committed to furthering research in the field of hepatology to improve the lives of everyone affected by liver disease. The combined efforts of all stakeholders in the public and private sectors and civil society are essential to halting and reversing liver disease. As such, EASL acknowledges that every voice is valued.
EASL embraces freedom of expression at The Digital International Liver Congress™ 2020, as an essential principle in the response to progressing liver disease and in promoting full participation during the congress. However, EASL is responsible for maintaining the safety of all attendees and as such, must balance the need of allowing all participants to be heard while ensuring events are not disrupted.
Please consult the EASL policy statement on equality, diversity, and inclusion.
05 August 2020
Significant unmet needs remain for patients with immune-mediated and cholestatic liver diseases, compounded by a broad disease manifestation…
20 July 2020
The curative potential of direct-acting antivirals (DAAs) for hepatitis C virus (HCV) infection have transformed hepatology in recent…
06 July 2020
As our knowledge of liver physiology expands, so too does our understanding of the critical role played by…